Total Payments
$5,661
2024 Payments
$1,442
Companies
31
Transactions
286
Medicare Patients
2,125
Medicare Billing
$137,474
Payment Breakdown by Category
Food & Beverage$5,280 (93.3%)
Education$380.68 (6.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,280 | 279 | 93.3% |
| Education | $380.68 | 7 | 6.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $735.73 | 51 | $0 (2024) |
| Janssen Biotech, Inc. | $718.50 | 34 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $611.97 | 15 | $0 (2024) |
| Incyte Corporation | $369.40 | 33 | $0 (2024) |
| Arcutis Biotherapeutics, Inc. | $294.74 | 20 | $0 (2024) |
| Stemline Therapeutics Inc. | $270.30 | 2 | $0 (2021) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $231.69 | 12 | $0 (2024) |
| Lilly USA, LLC | $221.90 | 11 | $0 (2024) |
| Amgen Inc. | $204.22 | 11 | $0 (2024) |
| PFIZER INC. | $196.02 | 16 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,442 | 88 | Janssen Biotech, Inc. ($282.44) |
| 2023 | $2,717 | 158 | Janssen Biotech, Inc. ($376.94) |
| 2022 | $728.12 | 33 | ABBVIE INC. ($139.12) |
| 2021 | $359.92 | 4 | Regeneron Healthcare Solutions, Inc. ($209.16) |
| 2019 | $413.47 | 3 | Mallinckrodt Enterprises LLC ($182.93) |
All Payment Transactions
286 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $21.49 | General |
| Category: DERMATOLOGY | ||||||
| 12/18/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $19.25 | General |
| Category: Dermatology | ||||||
| 08/28/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $14.17 | General |
| Category: Inflammation | ||||||
| 08/07/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $13.40 | General |
| Category: Dermatology | ||||||
| 08/01/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $32.87 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 07/31/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $23.42 | General |
| Category: Inflammation | ||||||
| 07/24/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $16.92 | General |
| Category: Dermatology | ||||||
| 07/24/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $7.76 | General |
| Category: IMMUNOLOGY | ||||||
| 07/22/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $17.06 | General |
| Category: DERMATOLOGY | ||||||
| 07/17/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $7.50 | General |
| Category: IMMUNOLOGY | ||||||
| 07/17/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $4.49 | General |
| Category: Dermatology | ||||||
| 07/09/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $19.18 | General |
| Category: IMMUNOLOGY | ||||||
| 07/09/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $12.39 | General |
| Category: Dermatology | ||||||
| 07/03/2024 | Ortho Dermatologics, a division of Bausch Health US, LLC | Cabtreo (Drug) | Food and Beverage | In-kind items and services | $20.16 | General |
| Category: Dermatology | ||||||
| 07/02/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $11.88 | General |
| Category: IMMUNOLOGY | ||||||
| 06/26/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $6.91 | General |
| Category: Immunology | ||||||
| 06/25/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $13.61 | General |
| Category: IMMUNOLOGY | ||||||
| 06/24/2024 | ABBVIE INC. | — | Education | In-kind items and services | $8.45 | General |
| 06/21/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $6.90 | General |
| Category: IMMUNOLOGY | ||||||
| 06/18/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $26.00 | General |
| Category: Immunology | ||||||
| 06/14/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $8.53 | General |
| Category: IMMUNOLOGY | ||||||
| 06/12/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $7.04 | General |
| Category: Immunology | ||||||
| 06/06/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $3.21 | General |
| Category: Dermatology | ||||||
| 06/05/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $14.09 | General |
| Category: Dermatology | ||||||
| 06/05/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $3.28 | General |
| Category: Dermatology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 1,638 | 2,514 | $257,515 | $108,889 |
| 2022 | 10 | 487 | 687 | $60,819 | $28,585 |
Total Patients
2,125
Total Services
3,201
Medicare Billing
$137,474
Procedure Codes
31
All Medicare Procedures & Services
31 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 342 | 411 | $53,713 | $22,784 | 42.4% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 317 | 397 | $38,242 | $15,608 | 40.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 120 | 149 | $27,605 | $12,849 | 46.5% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 135 | 146 | $21,076 | $8,771 | 41.6% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 36 | 42 | $18,311 | $8,547 | 46.7% |
| 96574 | Application of light with debridement to destroy precancer skin growth | Office | 2023 | 13 | 31 | $12,265 | $6,233 | 50.8% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 78 | 97 | $15,670 | $6,110 | 39.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 83 | 83 | $13,490 | $4,738 | 35.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 100 | 107 | $8,713 | $3,890 | 44.6% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 209 | 791 | $7,473 | $3,744 | 50.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 27 | 27 | $6,545 | $3,076 | 47.0% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 24 | 27 | $9,487 | $2,486 | 26.2% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 45 | 45 | $4,663 | $1,714 | 36.8% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 12 | 14 | $3,389 | $1,647 | 48.6% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 11 | 12 | $3,086 | $1,465 | 47.5% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 16 | 16 | $2,871 | $1,406 | 49.0% |
| 11603 | Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | Office | 2023 | 11 | 11 | $4,437 | $1,159 | 26.1% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 20 | 27 | $1,940 | $914.43 | 47.1% |
| 11310 | Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, 0.5 cm or less | Office | 2023 | 11 | 11 | $1,838 | $873.20 | 47.5% |
| 11301 | Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm | Office | 2023 | 14 | 15 | $2,615 | $827.04 | 31.6% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 14 | 55 | $87.69 | $44.99 | 51.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 115 | 122 | $16,210 | $7,891 | 48.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 94 | 102 | $9,968 | $4,086 | 41.0% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 42 | 46 | $7,527 | $3,749 | 49.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 46 | 46 | $7,579 | $3,570 | 47.1% |
About Dr. Sara Huff, MD
Dr. Sara Huff, MD is a Dermatology healthcare provider based in Westerville, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/18/2018. The National Provider Identifier (NPI) number assigned to this provider is 1386147197.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sara Huff, MD has received a total of $5,661 in payments from pharmaceutical and medical device companies, with $1,442 received in 2024. These payments were reported across 286 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($5,280).
As a Medicare-enrolled provider, Huff has provided services to 2,125 Medicare beneficiaries, totaling 3,201 services with total Medicare billing of $137,474. Data is available for 2 years (2022–2023), covering 31 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Westerville, OH
- Active Since 03/18/2018
- Last Updated 12/09/2025
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1386147197
Products in Payments
- DUPIXENT (Biological) $723.29
- TREMFYA (Drug) $691.48
- SKYRIZI (Biological) $510.97
- OPZELURA (Drug) $369.40
- TALTZ (Drug) $221.90
- RINVOQ (Biological) $216.31
- Otezla (Drug) $204.22
- VTAMA (Drug) $192.25
- CELLEX/XTS PHOTOPHERESIS SYSTEM (Device) $182.93
- COSENTYX (Drug) $177.81
- Sotyktu (Drug) $169.21
- EUCRISA (Drug) $145.96
- REMICADE (Biological) $128.90
- ELZONRIS (Drug) $119.54
- ADBRY (Biological) $119.54
- AMELUZ (Drug) $89.67
- ILUMYA (Biological) $78.56
- XTRAC (Device) $77.14
- Winlevi (Drug) $65.82
- LIBTAYO (Biological) $55.67
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Westerville
Dr. Joshua Grosshandler, M.d, M.D
Dermatology — Payments: $378,447
Dermatology $378,447
Jess Demaria, Md, MD
Dermatology — Payments: $195,915
Dermatology $195,915
Dr. Brittany Dulmage, M.d, M.D
Dermatology — Payments: $18,054
Dermatology $18,054
Rosina Lin, M.d, M.D
Dermatology — Payments: $17,300
Dermatology $17,300
Dr. Kevin Karikomi, D.o, D.O
Dermatology — Payments: $14,525
Dermatology $14,525
Jennifer Nash, M.d, M.D
Dermatology — Payments: $9,506
Dermatology $9,506